Publications

Shingleton, JR, and Dave, SS. "TET2 Deficiency Sets the Stage for B-cell Lymphoma." Cancer Discovery 8, no. 12 (December 2018): 1515-1517.

PMID
30510015
Full Text

Abonour, R, Wagner, L, Durie, BGM, Jagannath, S, Narang, M, Terebelo, HR, Gasparetto, CJ, Toomey, K, Hardin, JW, Kitali, A, Gibson, CJ, Srinivasan, S, Swern, AS, and Rifkin, RM. "Impact of post-transplantation maintenance therapy on health-related quality of life in patients with multiple myeloma: data from the Connect® MM Registry." Annals of Hematology 97, no. 12 (December 2018): 2425-2436.

PMID
30056582
Full Text

El-Jawahri, A, LeBlanc, TW, Burns, LJ, Denzen, E, Meyer, C, Mau, L-W, Roeland, EJ, Wood, WA, and Petersdorf, E. "What do transplant physicians think about palliative care? A national survey study." December 2018.

PMID
30289980
Full Text

Kelly, KR, Friedberg, JW, Park, SI, McDonagh, K, Hayslip, J, Persky, D, Ruan, J, Puvvada, S, Rosen, P, Iyer, SP, Stefanovic, A, Bernstein, SH, Weitman, S, Karnad, A, Monohan, G, VanderWalde, A, Mena, R, Schmelz, M, Spier, C, Groshen, S, Venkatakrishnan, K, Zhou, X, Sheldon-Waniga, E, Leonard, EJ, and Mahadevan, D. "Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma." Clinical Cancer Research : an Official Journal of the American Association for Cancer Research 24, no. 24 (December 2018): 6150-6159.

PMID
30082475
Full Text

Bahlis, NJ, Sutherland, H, White, D, Sebag, M, Lentzsch, S, Kotb, R, Venner, CP, Gasparetto, C, Del Col, A, Neri, P, Reece, D, Kauffman, M, Shacham, S, Unger, TJ, Jeha, J, Saint-Martin, J-R, Shah, J, and Chen, C. "Selinexor plus low-dose bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma." Blood 132, no. 24 (December 2018): 2546-2554.

PMID
30352784
Full Text

Paul, B, Kang, S, Zheng, Z, and Kang, Y. "The challenges of checkpoint inhibition in the treatment of multiple myeloma." Cellular Immunology 334 (December 2018): 87-98. (Review)

PMID
30342750
Full Text

Webb, JA, Kamal, AH, and LeBlanc, TW. "A New Frontier for Palliative Care: The Need to Train Palliative-Oncology Subspecialists." Journal of Palliative Medicine 21, no. 12 (December 1, 2018): 1679-1680. (Letter)

Full Text

LeBlanc, TW, and El-Jawahri, A. "Hemato-oncology and palliative care teams: is it time for an integrated approach to patient care?." Current Opinion in Supportive and Palliative Care 12, no. 4 (December 2018): 530-537.

PMID
30379755
Full Text

Friedman, DR, Guadalupe, E, Volkheimer, A, Moore, JO, and Weinberg, JB. "Clinical outcomes in chronic lymphocytic leukaemia associated with expression of CD5, a negative regulator of B-cell receptor signalling." British Journal of Haematology 183, no. 5 (December 2018): 747-754.

PMID
30407619
Full Text

Woyach, JA, Ruppert, AS, Heerema, NA, Zhao, W, Booth, AM, Ding, W, Bartlett, NL, Brander, DM, Barr, PM, Rogers, KA, Parikh, SA, Coutre, S, Hurria, A, Brown, JR, Lozanski, G, Blachly, JS, Ozer, HG, Major-Elechi, B, Fruth, B, Nattam, S, Larson, RA, Erba, H, Litzow, M, Owen, C, Kuzma, C, Abramson, JS, Little, RF, Smith, SE, Stone, RM, Mandrekar, SJ, and Byrd, JC. "Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL." The New England Journal of Medicine 379, no. 26 (December 2018): 2517-2528.

PMID
30501481
Full Text

Pages